Tristan Snell
A
BREAKING -- the DEA is reclassifying cannabis from a Schedule I to a Schedule III drug

Major move from the Biden Administration that will allow cannabis companies to have easier access to banking, investment, and tax credits -- and it opens the door to more medical research
05:27 PM - Apr 30, 2024
Avatar Avatar Avatar
0
6
153
JIlda Nettleton
A
this will make it easier for people to research cannabis effects of the body and brain. Just a warning - some of you may not like all the answers.
In response to Tristan Snell.
11:58 PM - Apr 30, 2024
0
1

 

{{ notificationModalContent }} {{ promptModalMessage }}